Abatacept + Adalimumab Afzb Interaction
Majorinteraction on record
Description
Increased risk of serious infection when combined with TNF blockers. Use not recommended in patients with RA due to no added benefit.
Mechanism
TNF blocker combined with other biologic immunosuppressant
Source: NLP:adalimumab-afzb